Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Jingfei Cheng, Holly Eggington, Yi-Jhih Huang, Zhe Huang and Joshua Moore who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detection conferences.

The mission of the Oxford Centre for Cancer Early Detection and Prevention (OxCODE) Travel Award is to raise the profile of Oxford’s early detection and precision prevention research by competitively funding the attendance of early career researchers (students and post-doctoral researchers, or equivalent) at two major annual cancer prevention and early detection conferences.

The Cancer Prevention Research conference is a new annual conference hosted by the American Cancer Society, the National Cancer Institute, and Cancer Research UK, which runs this year from 25-27th June. The Early Detection of Cancer conference runs this year from 22-24th October in San Francisco.

After peer review by the OxCODE Operational Group, funds were allocated to the following people:

  • Dr Jingfei Cheng (Song group, Ludwig Institute for Cancer Research) “A human tissue atlas of DNA methylation and hydroxymethylation”
  • Holly Eggington (Leedham group, Centre for Human Genetics) “BMP modulation suppresses the stem cell niche to prevent disease onset in a model of hereditary colorectal cancer”
  • Dr Yi-Jhih Huang (Vallis group, Department of Oncology) “Molecular Imaging for the Detection of Barrett’s Esophagus, Esophageal Dysplasia and Adenocarcinoma using a c-Met Specific Peptide”
  • Dr Zhe Huang (Travis group, Oxford Population Health) “Proteomic risk factors for prostate cancer: a case-cohort study in EPIC”
  • Dr Joshua Moore (Byrne group, Mathematical Institute) “Towards spatial hallmarks of cancer detection and treatment”


Congratulations to these awardees and thank you to all applicants for their submissions.